👥 HR & Workplace🇮🇳 India
Dr. Reddy's Profit Crashes 69% in Q1 — A Rough Quarter for India's Pharma Giant
Mint·Thursday, 23 July 2026
Dr. Reddy's Laboratories reported a sharp fall in net profit to ₹444 crore in the first quarter of FY27, down 69% from a year ago. Revenue also dropped 5.6% to ₹8,071 crore, missing analyst estimates. The results came in below expectations across the board.
Why It Matters
Dr. Reddy's is one of India's largest pharmaceutical companies and a major employer. Its performance is a barometer for the Indian generic drug industry.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.